Rakhi Kumar's Insider Trades & SAST Disclosures
Rakhi Kumar's most recent trade in Roivant Sciences Ltd was a trade of 958 Common Shares done at an average price of $10.7 . Disclosure was reported to the exchange on Feb. 20, 2025.
Add Superstar Alert
Share
Note
This is a custom search result for pattern Rakhi Kumar.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 10.72 per share. | 20 Feb 2025 | 958 | 162,306 | - | 10.7 | 10,270 | Common Shares |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | Sale of securities on an exchange or to another person at price $ 10.43 per share. | 13 Feb 2025 | 227,500 | 163,264 | - | 10.4 | 2,372,825 | Common Shares |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 3.85 per share. | 13 Feb 2025 | 187,500 | 390,764 | - | 3.9 | 721,875 | Common Shares |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 13 Feb 2025 | 187,500 | 312,500 | - | - | Stock Option (Right to Buy) | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | Payment of exercise price or tax liability using portion of securities received from the company at price $ 11.15 per share. | 20 Jan 2025 | 1,057 | 203,264 | - | 11.2 | 11,786 | Common Shares |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 20 Dec 2024 | 3,087 | 204,321 | - | 11.6 | 35,717 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 20 Nov 2024 | 958 | 207,408 | - | 11.5 | 11,007 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 20 Oct 2024 | 956 | 208,366 | - | 11.9 | 11,396 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 20 Sep 2024 | 250,000 | 459,322 | - | 3.9 | 962,500 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 20 Sep 2024 | 250,000 | 500,000 | - | - | Stock Option (Right to Buy) | ||
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 20 Sep 2024 | 250,000 | 209,322 | - | 11.9 | 2,972,500 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 20 Sep 2024 | 3,087 | 209,322 | - | 12.0 | 36,951 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 20 Aug 2024 | 958 | 212,409 | - | 11.5 | 10,998 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 20 Jul 2024 | 958 | 213,367 | - | 11 | 10,538 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 20 Jun 2024 | 3,087 | 212,123 | - | 10.8 | 33,340 | Common Shares | |
| NeuroPace Inc | Rakhi Kumar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 07 Jun 2024 | 17,774 | 17,774 | - | - | Stock Option (Rt to Buy) | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 20 May 2024 | 1,363 | 215,210 | - | 11.4 | 15,497 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 22 Apr 2024 | 230,548 | 230,548 | - | - | Stock Option (Right to Buy) | ||
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 22 Apr 2024 | 38,685 | 216,573 | - | 0 | Common Shares | ||
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 20 Apr 2024 | 9,881 | 177,888 | - | 10.5 | 103,355 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 20 Mar 2024 | 1,506 | 187,769 | - | 10.0 | 15,075 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 20 Feb 2024 | 1,508 | 189,275 | - | 11.5 | 17,402 | Common Shares | |
| Roivant Sciences Ltd | Kumar Rakhi | Chief Accounting Officer | 20 Jan 2024 | 1,506 | 190,783 | - | 10.3 | 15,587 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 27 Dec 2023 | 1,894 | 87,126 | - | - | Capped Value Appreciation Rights | ||
| Roivant Sciences Ltd | Kumar Rakhi | Chief Accounting Officer | 27 Dec 2023 | 13 | 192,295 | - | - | Common Shares | ||
| Roivant Sciences Ltd | Kumar Rakhi | Chief Accounting Officer | 27 Dec 2023 | 6 | 192,289 | - | 11.5 | 69 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 22 Aug 2023 | 1,378 | 197,950 | - | 10.8 | 14,924 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 01 Aug 2023 | 3,681 | 101,074 | - | - | Stock Option (Right to Buy) | ||
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 01 Aug 2023 | 3,681 | 199,328 | - | 12 | 44,172 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 01 Aug 2023 | 3,681 | 203,009 | - | 6.5 | 23,853 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 01 Aug 2023 | 336 | 104,755 | - | - | Stock Option (Right to Buy) | ||
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 01 Aug 2023 | 336 | 199,328 | - | 12 | 4,032 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 01 Aug 2023 | 336 | 199,664 | - | 6.5 | 2,177 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 24 Jul 2023 | 1,393 | 199,328 | - | 11.0 | 15,309 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 14 Jul 2023 | 535 | 82,128 | - | 12 | 6,420 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 14 Jul 2023 | 535 | 105,191 | - | - | Stock Option (Right to Buy) | ||
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 14 Jul 2023 | 535 | 82,663 | - | 6.5 | 3,467 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 14 Jul 2023 | 100 | 105,091 | - | - | Stock Option (Right to Buy) | ||
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 14 Jul 2023 | 100 | 82,128 | - | 12 | 1,200 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 14 Jul 2023 | 100 | 82,228 | - | 6.5 | 648 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 22 Jun 2023 | 1,357 | 197,225 | - | 10.0 | 13,584 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 09 Jun 2023 | 43,893 | 242,475 | - | 5.1 | 224,732 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 09 Jun 2023 | 43,893 | 0 | - | - | Stock Option (Right to Buy) | ||
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 09 Jun 2023 | 43,893 | 198,582 | - | 9.9 | 435,857 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 23 May 2023 | 1,557 | 198,582 | - | 9.6 | 14,916 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 01 May 2023 | 62,219 | 200,139 | - | 8.6 | 533,839 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 01 May 2023 | 62,219 | 765,517 | - | - | Stock Option (Right to Buy) | ||
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 01 May 2023 | 62,219 | 262,358 | - | 3.8 | 239,543 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 01 May 2023 | 15,517 | 750,000 | - | - | Stock Option (Right to Buy) | ||
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 01 May 2023 | 15,517 | 200,139 | - | 8.4 | 130,653 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 01 May 2023 | 15,517 | 215,656 | - | 3.8 | 59,740 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 20 Apr 2023 | 286,408 | 286,408 | - | - | Stock Option (Right to Buy) | ||
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 20 Apr 2023 | 66,710 | 201,708 | - | 0 | Common Shares | ||
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 20 Apr 2023 | 1,569 | 200,139 | - | 8.8 | 13,807 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 23 Mar 2023 | 2,134 | 130,409 | - | 7.3 | 15,578 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 22 Feb 2023 | 1,797 | 132,543 | - | 8.4 | 15,149 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 24 Jan 2023 | 1,838 | 134,340 | - | 8.6 | 15,733 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 23 Dec 2022 | 1,592 | 136,178 | - | 7.1 | 11,303 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 20 Nov 2022 | 1,584 | 137,770 | - | 5 | 7,920 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 25 Oct 2022 | 1,588 | 139,354 | - | 4.4 | 6,987 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 23 Sep 2022 | 1,741 | 140,942 | - | 3.1 | 5,345 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 24 Aug 2022 | 1,652 | 142,683 | - | 3.7 | 6,129 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 25 Jul 2022 | 1,686 | 144,335 | - | 4.3 | 7,300 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 23 Jun 2022 | 1,635 | 146,021 | - | 4.3 | 7,096 | Common Shares | |
| NeuroPace Inc | Rakhi Kumar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 13 Jun 2022 | 18,253 | 18,253 | - | - | Stock Option (Right to Buy) | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 20 May 2022 | 12,127 | 147,656 | - | 3.7 | 44,870 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 25 Apr 2022 | 703 | 159,783 | - | 3.8 | 2,700 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 30 Mar 2022 | 2,486 | 162,563 | - | 4.8 | 12,032 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 30 Mar 2022 | 2,077 | 160,486 | - | 4.7 | 9,845 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 25 Mar 2022 | 7,281 | 165,049 | - | 5.1 | 36,842 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 18 Mar 2022 | 2,153 | 172,330 | - | 5.1 | 11,045 | Common Shares | |
| Roivant Sciences Ltd | Rakhi Kumar | Chief Accounting Officer | 07 Mar 2022 | 3,091 | 174,483 | - | 5.5 | 17,062 | Common Shares | |
| NeuroPace Inc | Rakhi Kumar | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 21 Apr 2021 | 21,698 | 21,698 | - | - | Stock Option (Right to Buy) |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges